These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6671416)

  • 21. Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory.
    Grevert P; Masover B; Goldstein A
    Arch Gen Psychiatry; 1977 Jul; 34(7):849-53. PubMed ID: 879977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings].
    Lehmann WX
    NIDA Res Monogr; 1976 Jul; (8):82-3. PubMed ID: 792705
    [No Abstract]   [Full Text] [Related]  

  • 24. Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats.
    Newman JL; Vann RE; May EL; Beardsley PM
    Psychopharmacology (Berl); 2002 Oct; 164(1):108-14. PubMed ID: 12373424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cooperative clinical study of methadyl acetate. I. Three-times-a-week regimen.
    Ling W; Klett CJ; Gillis RD
    Arch Gen Psychiatry; 1978 Mar; 35(3):345-53. PubMed ID: 727887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of acetylmethadol or methadone with other drugs in rhesus monkeys.
    Downs DA
    Pharmacol Biochem Behav; 1979 Mar; 10(3):407-14. PubMed ID: 109865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phase III clinical evaluation of LAAM: I. Comparative epidemiology of mortality in LAAM and methadone.
    Thomas DB; Whysner JA; Newmann MC
    NIDA Res Monogr; 1979; 27():289-295b. PubMed ID: 121344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone/LAAM maintenance: a comparison study.
    Savage C; Karp EG; Curran SF; Hanlon TE; McCabe OL
    Compr Psychiatry; 1976; 17(3):415-24. PubMed ID: 776522
    [No Abstract]   [Full Text] [Related]  

  • 30. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
    Anglin MD; Conner BT; Annon J; Longshore D
    Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
    Mendelson JH; Ellingboe J; Judson BA; Goldstein A
    Clin Pharmacol Ther; 1984 Apr; 35(4):545-7. PubMed ID: 6705455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.
    Anglin MD; Conner BT; Annon JJ; Longshore D
    J Behav Health Serv Res; 2009 Apr; 36(2):267-82. PubMed ID: 19023658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the relative efficacy of LAAM and methadone.
    Whysner JA; Thomas DB; Ling W; Charuvastra C
    NIDA Res Monogr; 1979; 27():429-33. PubMed ID: 121364
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinical experience with LAAM.
    Goldstein A
    NIDA Res Monogr; 1976 Jul; (8):115-7. PubMed ID: 995176
    [No Abstract]   [Full Text] [Related]  

  • 38. 1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlates.
    Young GA; Moreton JE; Meltzer LT; Khazan N
    Drug Alcohol Depend; 1977 Mar; 2(2):141-8. PubMed ID: 192530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.
    Marcovici M; O'Brien CP; McLellan AT; Kacian J
    Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SAODAP cooperative studies of LAAM: unblinded comparison with methadone.
    Klett CJ
    NIDA Res Monogr; 1978; (19):271-6. PubMed ID: 106292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.